Venture Capital Activity Declines in Third Quarter of 2011
Double digit decrease in both number of deals and total investments when compared to Q2 2011
These results were outlined in the MoneyTree Report survey, which is produced by PricewaterhouseCoopers LLP and the National Venture Capital Association (NVCA).
Although Biotechnology investments declined from Q2 to Q3 2011, Biotechnology continued to be the second largest sector in terms of monies invested. Cleantechnology ventures experienced a decline in both the number of deals and dollars invested for the same period. Both industries are heavily influenced by public policy decisions and challenges, which has led to slower growth, but these industries are not down and out by any means. Both industries continue to be innovative and generate new companies every day.
Software ventures not only dominated the venture capital market for Q3 2011, it saw its highest number of investments completed since the last quarter of 2001. Cleantechnology ventures experienced a decline in both the number of deals and dollars invested for the same period.
Based on stage of development, from Q2 to Q3 2011, only Expansion stage investment experienced an increase in dollars invested (2%). Seed stage investments decreased 56% percent, followed by Later stage (-20%), and Early stage investing (-7%).